Time to sustained improvement in bowel movement frequency with telotristat ethyl: Analysis of the phase III telecast study.

Authors

null

Joseph Dillon

University of Iowa, Iowa City, IA

Joseph Dillon , Pablo Lapuerta , Chad McKee

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02063659

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 395)

DOI

10.1200/JCO.2018.36.4_suppl.395

Abstract #

395

Poster Bd #

J9

Abstract Disclosures

Similar Posters

Poster

2019 Gastrointestinal Cancers Symposium

Evaluation of disease-specific and functional symptom items on carcinoid tumor patients treated with telotristat ethyl.

Evaluation of disease-specific and functional symptom items on carcinoid tumor patients treated with telotristat ethyl.

First Author: Stacie Hudgens

First Author: Michal Mego

First Author: Mark Andrew Dickson